-
EP3134095
European procedure
Extract from the Register of European Patents
EP About this file: EP3134095
| EP3134095 - IMPROVED METHODS FOR MANUFACTURING ADOPTIVE CELL THERAPIES [Right-click to bookmark this link] | Status | The patent has been granted Status updated on 20.03.2020 Database last updated on 26.04.2025 | |
| Former | Grant of patent is intended Status updated on 11.03.2020 | ||
| Former | Examination is in progress Status updated on 06.12.2019 | ||
| Former | Grant of patent is intended Status updated on 30.07.2019 | ||
| Former | Examination is in progress Status updated on 13.04.2018 | ||
| Former | Request for examination was made Status updated on 27.01.2017 | ||
| Former | The international publication has been made Status updated on 14.11.2016 | Most recent event Tooltip | 24.05.2024 | Opposition withdrawn | published on 26.06.2024 [2024/26] | Applicant(s) | For all designated states 2seventy bio, Inc. 60 Binney Street Cambridge, MA 02142 / US | [2021/44] |
| Former [2020/17] | For all designated states Bluebird Bio, Inc. 60 Binney Street Cambridge, MA 02142 / US | ||
| Former [2017/20] | For all designated states Bluebird Bio, Inc. 60 Binney Street Cambridge, MA 02142 / US | ||
| Former [2017/18] | For all designated states Bluebird Bio, Inc. 60 Binney Street Cambridge, MA 02141 / US | ||
| Former [2017/09] | For all designated states Bluebird Bio, Inc. 150 Second Street Cambridge, MA 02141 / US | Inventor(s) | 01 /
MORGAN, Richard PO Box 1254 Center Harbor NH 03226-1254 / US | 02 /
FRIEDMAN, Kevin 4 Clover Circle Medford, Massachusetts 02176 / US | 03 /
MAIER, Dawn 29 Crestwood Road North Reading, Massachusetts 01864 / US | [2017/13] |
| Former [2017/11] | 01 /
MORGAN, Richard 6922 Tolling Bells Court Columbia, Maryland 21044 / US | ||
| 02 /
FRIEDMAN, Kevin 4 Clover Circle Medford, Massachusetts 02176 / US | |||
| 03 /
MAIER, Dawn 29 Crestwood Road North Reading, Massachusetts 01864 / US | |||
| Former [2017/09] | 01 /
MORGAN, Richard 6922 Tolling Bells Court Columbia, Maryland 21044 / US | ||
| 02 /
FRIEDMAN, Kevin 10 Museum Way 1123 Cambridge, Massachusetts 02141 / US | |||
| 03 /
MAIER, Dawn 103 Lowell Road Apt. 105 North Reading, Massachusetts 01864 / US | Representative(s) | Forresters IP LLP Skygarden Erika-Mann-Straße 11 80636 München / DE | [N/P] |
| Former [2020/17] | Donald, Jenny Susan Forresters IP LLP Skygarden Erika-Mann-Strasse 11 80636 München / DE | ||
| Former [2017/09] | Cooley (UK) LLP Dashwood 69 Old Broad Street London EC2M 1QS / GB | Application number, filing date | 15783117.3 | 24.04.2015 | [2017/09] | WO2015US27518 | Priority number, date | US201461984558P | 25.04.2014 Original published format: US 201461984558 P | [2017/09] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2015164745 | Date: | 29.10.2015 | Language: | EN | [2015/43] | Type: | A1 Application with search report | No.: | EP3134095 | Date: | 01.03.2017 | Language: | EN | The application published by WIPO in one of the EPO official languages on 29.10.2015 takes the place of the publication of the European patent application. | [2017/09] | Type: | B1 Patent specification | No.: | EP3134095 | Date: | 22.04.2020 | Language: | EN | [2020/17] | Search report(s) | International search report - published on: | US | 29.10.2015 | (Supplementary) European search report - dispatched on: | EP | 22.08.2017 | Classification | IPC: | A61K35/12, A61K35/17, A61K38/17, C12N5/0783, C12N5/16, C12N7/00, C12N15/86 | [2017/38] | CPC: |
C12N5/0636 (EP,IL,KR,RU,US);
A61K35/17 (KR);
A61K38/177 (EP,IL,KR,US);
A61K40/11 (EP,IL,RU,US);
A61K40/31 (EP,IL,RU,US);
A61K40/4211 (EP,IL,RU,US);
A61K40/4215 (EP,IL,RU,US);
A61P29/00 (EP,IL);
A61P31/00 (EP,IL);
A61P35/00 (EP,IL);
A61P37/04 (EP,IL);
A61P37/06 (EP,IL);
C12N15/86 (IL,US);
C12N5/10 (RU);
C12N7/00 (IL,US);
A61K2035/124 (IL,US);
C07K14/7051 (EP);
C07K2319/00 (EP,IL,KR,US);
C07K2319/03 (EP);
C12N2501/2301 (IL,US);
C12N2501/998 (IL,US);
C12N2740/10043 (IL,US);
C12N2740/15043 (IL,US);
C12N2799/021 (EP,IL,US);
|
| Former IPC [2017/09] | A61K35/17, C12N5/0783, C12N5/16 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2017/09] | Extension states | BA | Not yet paid | ME | Not yet paid | Validation states | MA | Not yet paid | Title | German: | VERBESSERTE VERFAHREN ZUR HERSTELLUNG ADOPTIVER ZELLTHERAPIEN | [2017/09] | English: | IMPROVED METHODS FOR MANUFACTURING ADOPTIVE CELL THERAPIES | [2017/09] | French: | PROCÉDÉS AMÉLIORÉS DE PRODUCTION DE THÉRAPIES REPOSANT SUR DES CELLULES ADOPTIVES | [2017/09] | Entry into regional phase | 14.11.2016 | National basic fee paid | 14.11.2016 | Search fee paid | 14.11.2016 | Designation fee(s) paid | 14.11.2016 | Examination fee paid | Examination procedure | 14.11.2016 | Examination requested [2017/09] | 14.11.2016 | Date on which the examining division has become responsible | 07.03.2018 | Amendment by applicant (claims and/or description) | 13.04.2018 | Despatch of a communication from the examining division (Time limit: M06) | 05.11.2018 | Reply to a communication from the examining division | 10.01.2019 | Despatch of a communication from the examining division (Time limit: M04) | 12.03.2019 | Reply to a communication from the examining division | 31.07.2019 | Communication of intention to grant the patent | 03.12.2019 | Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO | 03.12.2019 | Fee for grant paid | 03.12.2019 | Fee for publishing/printing paid | 11.03.2020 | Information about intention to grant a patent | 11.03.2020 | Receipt of the translation of the claim(s) | Divisional application(s) | EP20170239.6 / EP3738597 | Opposition(s) | Opponent(s) | 01
19.01.2021
21.01.2021
ADMISSIBLE Dehns Limited 10 Salisbury Square London EC4Y 8JD / GB Opponent's representative Dehns 10 Old Bailey London EC4M 7NG / GB | 02
21.01.2021
26.01.2021
WITHDRAWN GlaxoSmithKline Intellectual Property Development Limited 980 Great West Road Brentford Middlesex TW8 9GS / GB Opponent's representative Chiappinelli, Susan Ann GSK Legal & Compliance - Global Patents 79 New Oxford Street London WC1A 1DG / GB | 03
22.01.2021
26.01.2021
ADMISSIBLE Boult Wade Tennant LLP Salisbury Square House 8, Salisbury Square London EC4Y 8AP / GB Opponent's representative Boult Wade Tennant LLP Salisbury Square House 8 Salisbury Square London EC4Y 8AP / GB | [N/P] |
| Former [2024/26] | |||
| Opponent(s) | 01
19.01.2021
21.01.2021
ADMISSIBLE Dehns Limited 10 Salisbury Square London EC4Y 8JD / GB Opponent's representative Dehns St. Bride's House 10 Salisbury Square London EC4Y 8JD / GB | ||
| 02
21.01.2021
26.01.2021
WITHDRAWN GlaxoSmithKline Intellectual Property Development Limited 980 Great West Road Brentford Middlesex TW8 9GS / GB Opponent's representative Chiappinelli, Susan Ann GlaxoSmithKline Global Patents (CN925.1) 980 Great West Road Brentford, Middlesex TW8 9GS / GB | |||
| 03
22.01.2021
26.01.2021
ADMISSIBLE Boult Wade Tennant LLP Salisbury Square House 8, Salisbury Square London EC4Y 8AP / GB Opponent's representative Boult Wade Tennant LLP Salisbury Square House 8 Salisbury Square London EC4Y 8AP / GB | |||
| Former [2022/08] | |||
| Opponent(s) | 01
19.01.2021
21.01.2021
ADMISSIBLE Dehns Limited 10 Salisbury Square London EC4Y 8JD / GB Opponent's representative Dehns St. Bride's House 10 Salisbury Square London EC4Y 8JD / GB | ||
| 02
21.01.2021
26.01.2021
ADMISSIBLE GlaxoSmithKline Intellectual Property Development Limited 980 Great West Road Brentford Middlesex TW8 9GS / GB Opponent's representative Chiappinelli, Susan Ann GlaxoSmithKline Global Patents (CN925.1) 980 Great West Road Brentford, Middlesex TW8 9GS / GB | |||
| 03
22.01.2021
26.01.2021
ADMISSIBLE Boult Wade Tennant LLP Salisbury Square House 8, Salisbury Square London EC4Y 8AP / GB Opponent's representative Boult Wade Tennant LLP Salisbury Square House 8 Salisbury Square London EC4Y 8AP / GB | |||
| Former [2021/15] | |||
| Opponent(s) | 01
19.01.2021
21.01.2021
ADMISSIBLE Dehns Limited 10 Salisbury Square London EC4Y 8JD / GB Opponent's representative Dehns St. Bride's House 10 Salisbury Square London EC4Y 8JD / GB | ||
| 02
21.01.2021
26.01.2021
ADMISSIBLE GlaxoSmithKline Intellectual Property Development Limited 980 Great West Road Brentford Middlesex TW8 9GS / GB Opponent's representative Harrison, Anna GlaxoSmithKline Global Patents (CN925.1) 980 Great West Road Brentford, Middlesex TW8 9GS / GB | |||
| 03
22.01.2021
26.01.2021
ADMISSIBLE Boult Wade Tennant LLP Salisbury Square House 8, Salisbury Square London EC4Y 8AP / GB Opponent's representative Boult Wade Tennant LLP Salisbury Square House 8 Salisbury Square London EC4Y 8AP / GB | |||
| Former [2021/09] | |||
| Opponent(s) | 01
19.01.2021
21.01.2021
ADMISSIBLE Dehns Limited 10 Salisbury Square London EC4Y 8JD / GB Opponent's representative Dehns St. Bride's House 10 Salisbury Square London EC4Y 8JD / GB | ||
| 02
21.01.2021
26.01.2021
ADMISSIBLE GlaxoSmithKline Intellectual Property Development Limited 980 Great West Road Brentford Middlesex TW8 9GS / GB Opponent's representative Harrison, Anna GlaxoSmithKline Global Patents (CN925.1) 980 Great West Road Brentford, Middlesex TW8 9GS / GB | |||
| 03
22.01.2021
26.01.2021
ADMISSIBLE Boult Wade Tennant LLP Salisbury Square House 8, Salisbury Square London EC4Y 8AP / GB Opponent's representative Boult Wade Tennant LLP Salisbury Square House 8 Salisbury Square London EC4Y 8AP / GB | |||
| Former [2021/08] | |||
| Opponent(s) | 01
19.01.2021
21.01.2021
ADMISSIBLE Dehns Limited 10 Salisbury Square London EC4Y 8JD / GB Opponent's representative Dehns St. Bride's House 10 Salisbury Square London EC4Y 8JD / GB | ||
| 02
21.01.2021
GlaxoSmithKline Intellectual Property Development Limited 980 Great West Road Brentford Middlesex TW8 9GS / GB Opponent's representative Harrison, Anna GlaxoSmithKline Global Patents (CN925.1) 980 Great West Road Brentford, Middlesex TW8 9GS / GB | 09.02.2021 | Invitation to proprietor to file observations on the notice of opposition | 18.08.2021 | Reply of patent proprietor to notice(s) of opposition | 30.01.2023 | Date of oral proceedings | 28.02.2023 | Despatch of interlocutory decision in opposition | 28.02.2023 | Despatch of minutes of oral proceedings | Appeal following opposition | 10.05.2023 | Appeal received No. T0868/23 | 10.05.2023 | Payment of appeal fee | 10.07.2023 | Statement of grounds filed | 17.06.2025 | Date of oral proceedings | Request for further processing for: | The application is deemed to be withdrawn due to failure to reply to the examination report | 05.11.2018 | Request for further processing filed | 05.11.2018 | Full payment received (date of receipt of payment) Request granted | 20.11.2018 | Decision despatched | Fees paid | Renewal fee | 27.04.2017 | Renewal fee patent year 03 | 09.04.2018 | Renewal fee patent year 04 | 08.04.2019 | Renewal fee patent year 05 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [Y]WO2012140130 (IMMUNICUM AB, et al); | [XY]WO2013126712 (UNIV PENNSYLVANIA [US]); | [XY]WO2014039523 (CELLECTIS [FR]); | International search | [Y]US7754482 (RILEY JAMES L [US], et al); | [XY]US7977095 (BONYHADI MARK [US], et al); | Opposition | US2008274091 | WO2012079000 | US2013280220 | US2012301447 | WO2013126712 | WO2014048920 | WO2014099671 |